Related Experiment Video
Updated: Sep 11, 2025

Author Spotlight: Tracing the Ferroptotic Signatures and Cell Death Dynamics in Medulloblastoma for Advanced Therapeutics
Published on: March 15, 2024
Prospects for ferroptosis therapies in cancer
Jessalyn M Ubellacker1, Scott J Dixon2
1Department of Molecular Metabolism, Harvard T.H. Chan School of Public Health, Boston, MA, USA. jubellacker@hsph.harvard.edu.
Abstract:
Ferroptosis is a nonapoptotic form of cell death characterized by lethal membrane lipid peroxidation. This mechanism was first characterized in cancer cells well over a decade ago, and there is much enthusiasm for the concept that certain cancers may be treated by inducing ferroptosis. However, therapies that engage ferroptosis have yet to enter clinical testing. In this Review, we highlight the gap between our rapidly expanding knowledge of the ferroptosis mechanism and its translation into cancer therapies. We discuss the known challenges that may be slowing ferroptosis therapies from reaching the clinic.
Insights
Ferroptosis, a cell death pathway, shows promise for cancer treatment. However, translating this knowledge into clinical therapies faces significant challenges that need to be addressed.
Area of Science:
- Biochemistry
- Cell Biology
- Oncology
Background:
- Ferroptosis is a distinct form of regulated cell death driven by lipid peroxidation.
- This cell death pathway has been extensively studied in cancer cells for over a decade.
- There is considerable interest in targeting ferroptosis for cancer therapy.
Purpose of the Study:
- To review the current understanding of ferroptosis.
- To highlight the gap between ferroptosis research and clinical applications in cancer therapy.
- To discuss challenges hindering the translation of ferroptosis-inducing therapies into clinical trials.
Main Methods:
- Literature review of ferroptosis mechanisms and cancer therapy research.
- Analysis of challenges in translating preclinical findings to clinical settings.
- Discussion of potential strategies to overcome therapeutic hurdles.
Main Results:
- Ferroptosis is a well-characterized cell death mechanism with therapeutic potential.
- Despite extensive research, no ferroptosis-inducing therapies have reached clinical trials.
- Several challenges impede the clinical translation of ferroptosis-based cancer treatments.
Conclusions:
- A significant gap exists between the scientific understanding of ferroptosis and its clinical application.
- Overcoming challenges in ferroptosis induction and delivery is crucial for developing effective cancer therapies.
- Further research and development are needed to bring ferroptosis-targeting treatments to cancer patients.
More Related Videos
08:02Isolation of Primary Cancer-Associated Fibroblasts from a Syngeneic Murine Model of Breast Cancer for the Study of Targeted Nanoparticles
Published on: May 14, 2021
09:21Ferritinophagy: Assessing the Selective Degradation of Iron by Autophagy in Human Fibroblasts
Published on: February 23, 2024
Related Concept Videos
Targeted Cancer Therapies
There are several types of targeted therapies against...
Necrosis
Morphological Manifestations of Necrosis
Necrotic cells show different types of morphological appearance depending on the type of tissue and infection. In coagulative necrosis, cells become...
Treatment Resistant Cancers
Cancer Therapies
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...